Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Heart and Vessels
Metadata
Title
Ventricular dysfunction in a patient with Plummer's disease: a case report
Authors
Ting-I Lee
Chien-Chu Lin
Tze-Sian Chan
Paul Chan
Y.-J. Chen
Publication date
01-04-2002
Publisher
Springer-Verlag Tokyo
Published in
Heart and Vessels / Issue 3/2002
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s003800200006

Other articles of this Issue 3/2002

Heart and Vessels 3/2002 Go to the issue

CASE REPORT

A case of hypereosinophilic syndrome presenting mid-ventricular obstruction

ORIGINAL ARTICLE

Assessment of left ventricular end-systolic elastance from aortic pressure-left ventricular volume relations

ORIGINAL ARTICLE

A free fatty acid tolerance test identifies patients with coronary artery disease among individuals with a low conventional coronary risk profile

ORIGINAL ARTICLE

Nitric oxide plays an insignificant role in direct vasodilator effects of calcium channel blockers in healthy humans

ORIGINAL ARTICLE

Compression and expansion wavefront travel in canine ascending aortic flow: wave intensity analysis

ORIGINAL ARTICLE

Short- and long-term outcomes of compromised side branches after Multi-Link stent implantation

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits